Tyme Technologies

$2.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-3.23%) Today
-$0.08 (-3.81%) As of 1:29 PM UTC after-hours

Why Robinhood?

You can buy or sell TYME and other stocks, options, and ETFs commission-free!

About TYME

Tyme Technologies, Inc. Common Stock, also called Tyme Technologies, is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. The listed name for TYME is Tyme Technologies, Inc. Common Stock.

CEO
Richard Anthony Cunningham
Employees
18
Headquarters
Bedminster, New Jersey
Founded
2011
Market Cap
361.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
10.49M
High Today
$2.19
Low Today
$2.03
Open Price
$2.14
Volume
4.99M
52 Week High
$4.99
52 Week Low
$0.85

TYME Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected May 19, After Hours

You May Also Like

MO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure